13
Views
15
CrossRef citations to date
0
Altmetric
Articles

The Effect of the New Triazole, Voriconazole (UK-109,496), on the Interactions of Candida albicans and Candida krusei with Endothelial Cells

Pages 7-16 | Published online: 18 Jul 2013

References

  • Fisher-Hoch SP, Hutwagner L. Opportunistic candidia-sis: an epidemic of the 1980s. Clin Infect Dis 1995; 21: 897–904.
  • Ghannoum MA, Radwan SS. The adherence process. In: Candida Adherence to Epithelial cells. Boca Raton, Florida CRC Press, 1990: 105-169.
  • Anderson ML, Odds FC. Adherence of Candida albi-cans to vaginal epithelia: significance of morpholopgical form and effect of ketoconazole. Mykosen 1985; 28: 531–540.
  • Ghannoum MA, Abu Elteen K. Correlative relationship between proteinase production, adherence and pathogenicity of various strains of Candida albicans. J Med Vet Mycol 1986; 24: 407–413.
  • Ghannoum MA, Filler SG, Ibrahim AS, Fu Y, Edwards JEJr. Modulation of interactions of Candida albicans and endothelial cells by fluconazole and amphotericin B. Antimicrob Agents Chemother 1992; 36: 2239–2244.
  • Liss RH, Letourneau RJ. Fungispecificity of fluconazole against Candida albicans. Mycopathologia 1989; 108: 173–178.
  • Macura AB. The influence of some antifungal drugs on in vitro adherence of Candida albicans to human buccal epithelial cells. Mycoses 1988; 31: 371–376.
  • Sobel JD, Obedeanu N. Effects of sub-inhibitory concen-trations of ketoconazole on in vitro adherence of Candida albicans to vaginal epithelial cells. Eur J Clin Microbiol 1983; 2: 445–452.
  • Yeaman MR, Sullam PM, Dazin PF, Ghannoum MA, Edwards JE, Bayer AS. Fluconazole and platelet microbicidal protein inhibit Candida adherence to platelets in vitro. Antimicrob Agents Chemother 1994; 38: 1460–1465.
  • Hitchcock CA, Pye GW, Oliver GP, Troke PF. UK-109,496: a novel, wide spectrum triazole derivative for the treatment of fungal infections: antifungal activity and selectivity in vitro. Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington DC, 1995: Abstr. # F72, p. 125.
  • Belanger P, Nast CC, Fratti R, Sanati H, Ghannoum M. Voriconazole (UK-109,496) inhibits the growth and alters the morphology of fluconazole-susceptible and -resistant Candida species. Antimicrob Agents Chemother 1997; 41: 1840–1842.
  • Sanati H, Belanger P, Fratti R, Ghannoum M. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei. Antimicrob Agents Chemother 1997; 41: 2492–2496.
  • Redding S, Smith J, Farinacci G, et al. Resistance of Candida albicans to fluconazole during treatment of oropha-ryngeal candidiasis in a patient with AIDS: Documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis 1994; 18: 240–242.
  • National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeast; tentative standard, M27T. National Committee for Clinical Laboratory Standards, Wayne, Pa, 1995.
  • Jaffe EA, Nachman RL, Becker CG, Ninick CR. Culture of human endothelial cells derived from umbilical veins: identi-fication by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745–2756.
  • Ghannoum MA, Abu Elteen K, Ellabib M, Whittaker PA. Antimycotic effects of cotenidine and pirtenidine. J Antimicrob Chemother 1990; 25: 237–245.
  • Ibrahim AS, Filler SG, Ghannoum MA, Edwards JEJr. Interferon-gamma protects endothelial cells from damage by Candida albicans. J Infect Dis 1993; 167: 2239–2244.
  • Abu El Teen K, Ghannoum M, Stretton RJ. Effects of sub-inhibitory concentrations of antifungal agents adherence of Candida spp. to buccal epithelial cells in vitro. Mycoses 1989; 32: 551–562.
  • Brenciaglia MI, Ghezzi MC, Cipriani P, Mancini C, Trancassini M. The influence of antifungal drugs on adherence of C. albicans to buccal epithelial cells. Chemioterapia 1986; 5: 200–203.
  • Mehentee JF, Hay RJ. Effect of antifungal agents on the adherence of Candida albicans to murine gastrointestinal mucosal surfaces. J Antimicrob Chemother 1990; 25: 111–119.
  • Van't Wout JW, Meynaar I, Linde I, Poe11 R, Matti H, Van Fuerth R. Effect of amphotericin B, fluconazole, and itra-conazole on intracellular Candida albicans and germ tube development in macrophages. J Antimicrob Chemother 1990; 25: 803-811.
  • Ghannoum MA, Radwan SS. Pathogenicity determi-nants in Candida. In: Candida Adherence to Epithelial cells. Boca Raton, Florida, CRC Press, 1990: 71-104.
  • Johnson EM, Warnock DW, Richardson MD, Douglas CJ. In-vitro effect of itraconazole, ketoconazole, and ampho-tericin B on phagocytic and candidacidal function of human neutrophils. J Antimicrob Chemother 1986; 18: 83–91.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.